Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
29396
¥ million (transferred assets, approximate)Wording
Definitive
How definitive the wording is.Decision and Details
Post-closing disclosure regarding the company split by HOYA Corporation and PENTAX Medical合同会社
DecisionAbsorption-type company split agreement dated 10 July 2025 and amendment agreement dated 26 March 2026
Implementation1 August 2026 (effective date; actual)
AmountTransferred assets: ¥29,396 million (approximate); transferred liabilities: ¥29,395 million (approximate)
Reason
To transfer to PENTAX Medical合同会社 the rights and obligations held by HOYA Corporation in relation to the relevant business, pursuant to the absorption-type company split agreement.
| Item | Details |
|---|---|
| Matter Covered | Post-closing disclosure regarding the company split by HOYA Corporation and PENTAX Medical合同会社 |
| Decision Date | Absorption-type company split agreement dated 10 July 2025 and amendment agreement dated 26 March 2026 |
| Implementation Date | 1 August 2026 (effective date; actual) |
| Amount | Transferred assets: ¥29,396 million (approximate); transferred liabilities: ¥29,395 million (approximate) |
| Reason | To transfer to PENTAX Medical合同会社 the rights and obligations held by HOYA Corporation in relation to the relevant business, pursuant to the absorption-type company split agreement. |
| Governing Rule | Companies Act, Article 791, paragraph 1, item 1; Article 791, paragraph 2; Article 801, paragraph 3, item 2; Companies Act Enforcement Regulations, Article 189; Companies Act, Article 784, paragraph 2; Articles 784-2, 785, 787, 789, 799 and 923 |
| Related previous disclosures | Absorption-type company split agreement dated 10 July 2025, amendment agreement relating to the absorption-type company split agreement dated 26 March 2026, and the Official Gazette notice and electronic public notice dated 23 July 2025 |
Items this document does not state (5)
Decision-Making BodyPeriod CoveredQuantity / scaleImpact on Business PerformanceFuture plans
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To transfer to PENTAX Medical合同会社 the rights and obligations held by HOYA Corporation in relation to the relevant business, pursuant to the company split agreement.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.